Anti-capsular polysaccharide antibody concentrations in saliva after immunization with Haemophilus influenzae type b conjugate vaccines.

No abstract is available for this paper.

• Publication year

  1995

• Venue

  The Pediatric Infectious Disease Journal

• Publication date

  1995-04-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1097/00006454-199504000-00008PMID 7603810
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Haemophilus influenzae type b carriage and immunity four years after receiving the Haemophilus influenzae oligosaccharide‐CRM197 (HbOC) conjugate vaccine

  1993cited by this paper
• Carriage of Haemophilus influenzae type b in children after widespread vaccination with conjugate Haemophilus influenzae type b vaccines

  1993cited by this paper
• Induction of immunologic memory in infants primed with Haemophilus influenzae type b conjugate vaccines.

  1993cited by this paper
• Decreased Haemophilus colonization in children vaccinated with Haemophilus influenzae type b conjugate vaccine.

  1993cited by this paper
• Vaccination with Haemophilus influenzae type b meningococcal protein conjugate vaccine reduces oropharyngeal carriage of Haemophilus influenzae type b among American Indian children

  1993cited by this paper
• Decline of childhood Haemophilus influenzae type b (Hib) disease in the Hib vaccine era.

  1993cited by this paper
• Anti-capsular polysaccharide antibodies reduce nasopharyngeal colonization by Haemophilus influenzae type b in infant rats.

  1993cited by this paper
• Detection of Haemophilus influenzae type B antigen in cerebrospinal fluid after immunization.

  1992cited by this paper
• Immunization with oligosaccharide conjugate Haemophilus influenzae type b (HbOC) vaccine on a large health maintenance organization population: extended follow-up and impact on Haemophilus influenzae disease epidemiology. The Kaiser Permanente Pediatric Vaccine Study Group.

  1992cited by this paper
• Immunisation of infants in Iceland against Haemophilus influenzae type b.

  1992cited by this paper
• Efficacy and safety of a Haemophilus influenzae type b capsular polysaccharide-tetanus protein conjugate vaccine.

  1992cited by this paper
• High antibody responses to booster doses of either Haemophilus influenzae capsular polysaccharide or conjugate vaccine after primary immunization with conjugate vaccines.

  1992cited by this paper
• Humoral immune response patterns of human mucosae: induction and relation to bacterial respiratory tract infections.

  1992cited by this paper
• Mucosal Antibodies to Haemophilus influenzae Type b Capsular Polysaccharide

  1991cited by this paper
• Antibody responses to four Haemophilus influenzae type b conjugate vaccines.

  1991cited by this paper
• The efficacy in Navajo infants of a conjugate vaccine consisting of Haemophilus influenzae type b polysaccharide and Neisseria meningitidis outer-membrane protein complex.

  1991cited by this paper
• Reduction of oropharyngeal carriage of Haemophilus influenzae type b (Hib) in children immunized with an Hib conjugate vaccine.

  1991cited by this paper
• Efficacy in infancy of oligosaccharide conjugate Haemophilus influenzae type b (HbOC) vaccine in a United States population of 61 080 children

  1991cited by this paper
• An ELISA employing a Haemophilus influenzae type b oligosaccharide-human serum albumin conjugate correlates with the radioantigen binding assay.

  1990cited by this paper
• A randomized, prospective field trial of a conjugate vaccine in the protection of infants and young children against invasive Haemophilus influenzae type b disease.

  1990cited by this paper
• Adoptive transfer of gut mucosal antitoxin memory by isolated B cells 1 year after oral immunization with cholera toxin

  1989cited by this paper
• Immunogenicity and reactogenicity of four Haemophilus influenzae type b capsular polysaccharide vaccines in Finnish 24-month-old children.

  1988cited by this paper
• Immunogenicity in infants of a vaccine composed of Haemophilus influenzae type b capsular polysaccharide mixed with DPT or conjugated to diphtheria toxoid.

  1987cited by this paper
• Antigenuria after Haemophilus influenzae type b polysaccharide vaccination.

  1986cited by this paper
• Effect of rifampin chemoprophylaxis on carriage eradication and new acquisition of Haemophilus influenzae type b in contacts.

  1985cited by this paper
• Serum antibodies after vaccination with Haemophilus influenzae type b capsular polysaccharide and responses to reimmunization: no evidence of immunologic tolerance or memory.

  1984cited by this paper
• Mucosal antibody response to parenteral vaccination with Haemophilus influenzae type b capsule.

  1983cited by this paper
• Further Studies on the Immunogenicity of Haemophilus influenzae Type b and Pneumococcal Type 6A Polysaccharide-Protein Conjugates

  1983cited by this paper
• Relationship between naturally occurring human mucosal and serum antibody to the capsular polysaccharide of Haemophilus influenzae type b.

  1982cited by this paper
• A mucosal antibody response following systemic Haemophilus influenzae type B infection in children.

  1981cited by this paper
• Quantitative immunohistochemistry of immunoglobulin- and J-chain-producing cells in human parotid and submandibular salivary glands.

  1980cited by this paper
• ELISA methodology for polysaccharide antigens: protein coupling of polysaccharides for adsorption to plastic tubes.

  1979cited by this paper
• Haemophilus influenzae type b capsular polysaccharide vaccine in children: a double-blind field study of 100,000 vaccinees 3 months to 5 years of age in Finland.

  1977cited by this paper
• Boosting of Secretory IgA Antibody Responses in Man by Parenteral Cholera Vaccination

  1977cited by this paper
• Factors affecting pharyngeal Haemophilus influenzae type b colonization rates in children

  1976cited by this paper
• Induction of serum Haemophilus influenzae type B capsular antibodies in adult volunteers fed cross-reacting Escherichia coli 075:K100:H5.

  1975cited by this paper

• The potential of saliva as an accessible and sensitive sample type for the detection of respiratory pathogens and host immunity

  2023cites this paper
• Induction of Susceptibility to Disseminated Infection with IgA1 Protease-Producing Encapsulated Pathogens Streptococcus pneumoniae, Haemophilus influenzae Type b, and Neisseria meningitidis

  2022cites this paper
• Naturally acquired antibody against Haemophilus influenzae type a in pediatric saliva.

  2022cites this paper
• Innovative Therapeutic and Vaccine Approaches against Respiratory Pathogens

  2020cites this paper
• Herd Protection against Meningococcal Disease through Vaccination

  2020cites this paper
• Microbial epidemiology and carriage studies for the evaluation of vaccines.

  2019cites this paper
• Systems Immunology Characterization of Novel Vaccine Formulations for Mycoplasma hyopneumoniae Bacterins

  2019influential citation
• Relationship between immune response to pneumococcal conjugate vaccines in infants and indirect protection after vaccine implementation

  2019cites this paper
• 15 – Combination Vaccines

  2018cites this paper
• Correlation of saliva and serum antibody titre response to pneumococcal capsular polysaccharides

  2017cites this paper
• Streptococcus pneumoniae Transmission Is Blocked by Type-Specific Immunity in an Infant Mouse Model

  2017cites this paper
• University of Birmingham The utility of saliva for the assessment of anti-pneumococcal antibodies:

  2016cites this paper
• The utility of saliva for the assessment of anti-pneumococcal antibodies: investigation of saliva as a marker of antibody status in serum

  2016cites this paper
• Parenteral Immunization and Protection from Mucosal Infection

  2015cites this paper
• Antibody blocks acquisition of bacterial colonization through agglutination

  2014cites this paper
• Enhancement of Serum and Mucosal Immune Responses to a Haemophilus influenzae Type B Vaccine by Intranasal Delivery

  2013cites this paper
• 40 – Combination vaccines

  2013cites this paper
• Evolving epidemiology of invasive Haemophilus infections in the post-vaccination era: results from a long-term population-based study.

  2012cites this paper
• Advances in Pneumococcal Vaccines

  2012cites this paper
• Two decades of experience with the Haemophilus influenzae serotype b conjugate vaccine in the United Kingdom.

  2012cites this paper
• Oropharyngeal carriage of respiratory bacteria among military conscripts

  2012cites this paper
• polysaccharide in healthy adults.

  2011cites this paper
• Serum Antibody Kinetics following Nasal or Parenteral Challenge with Meningococcal Polysaccharide in Healthy Adults

  2011cites this paper
• The continuing role of Haemophilus influenzae type b carriage surveillance as a mechanism for early detection of invasive disease activity

  2011cites this paper
• Haemophilus influenzae type b carriage in Indigenous children and children attending childcare centers in the Northern Territory, Australia, spanning pre- and post-vaccine eras.

  2011cites this paper
• Alphavirus replicon-based enhancement of mucosal and systemic immunity is linked to the innate response generated by primary immunization.

  2010cites this paper
• Nonmucosal Alphavirus Vaccination Stimulates a Mucosal Inductive Environment in the Peripheral Draining Lymph Node1

  2008cites this paper
• Combination vaccines containing DTPa–Hib: impact of IPV and coadministration of CRM197 conjugates

  2008cites this paper
• Sentido y ciencia de la inmunización infantil: ¿es posible que podamos obtener más con menos?*

  2007cites this paper
• Anticapsular serum antibody concentration and protection against pneumococcal colonization among children vaccinated with 7-valent pneumococcal conjugate vaccine.

  2007cites this paper
• Anticapsular Polysaccharide IgG Concentrations in Mexican Children Formerly Immunized with Haemophilus Influenzae b Prp-T Vaccine

  2007cites this paper
• Immunologic Response to Haemophilus influenzae Type b (Hib) Conjugate Vaccine and Risk Factors for Carriage among Hib Carriers and Noncarriers in Southwestern Alaska

  2006influential citation
• Sense and the science of childhood immunization: can we achieve more with less?

  2006cites this paper
• Identification of in vivo-expressed antigens of Staphylococcus aureus and their use in vaccinations for protection against nasal carriage.

  2006cites this paper
• Parenteral Immunization Induces Mucosal Protection: A Challenge to the Mucosal Immunity Paradigm

  2005cites this paper
• Serum serotype-specific pneumococcal anticapsular immunoglobulin g concentrations after immunization with a 9-valent conjugate pneumococcal vaccine correlate with nasopharyngeal acquisition of pneumococcus.

  2005cites this paper
• Influence of age and carriage status on salivary IgA to Neisseria meningitidis

  2005cites this paper
• Priming of Immunological Memory by Pneumococcal Conjugate Vaccine in Children Unresponsive to 23-Valent Polysaccharide Pneumococcal Vaccine

  2005cites this paper
• Salivary antibodies induced by the seven-valent PncCRM conjugate vaccine in the Finnish Otitis Media Vaccine Trial.

  2004cites this paper
• Evaluation of the continuing effectiveness of the United Kingdom's Haemophilus influenzae type b national immunisation programme

  2004cites this paper
• Haemophilus influenzae type b conjugate vaccines

  2004cites this paper
• Changing the Ecology of Pneumococci with Antibiotics and Vaccines

  2004cites this paper
• Indirect protection obtained by Haemophilus influenzae type b vaccination: analysis in a structured population model

  2004cites this paper
• Salivary Antibodies to Capsular Polysaccharides Induced by Polysaccharide-Protein Conjugate Vaccines in Infants

  2004influential citation
• Mucosal immunology of vaccines against pathogenic nasopharyngeal bacteria

  2004cites this paper
• Effect of the 7-valent pneumococcal conjugate vaccine on nasopharyngeal colonization by Streptococcus pneumoniae in the first 2 years of life.

  2004cites this paper
• Immunogenicity of pneumococcal vaccination of patients with cochlear implants.

  2004cites this paper
• Effects of Sample Collection and Storage Methods on Antipneumococcal Immunoglobulin A in Saliva

  2003cites this paper
• Mucosal Vaccination Against Encapsulated Respiratory Bacteria – New Potentials for Conjugate Vaccines?

  2003cites this paper
• Global reduction of Hib disease: what are the next steps? Proceedings of the meeting Scottsdale, Arizona, September 22-25, 2002.

  2003cites this paper
• Mucosal antibodies to protein and capsular polysaccharide antigens of streptococcus pneumoniae in children

  2003cites this paper
• Evaluation of diagnostic tests for influenza in a pediatric practice

  2002cites this paper
• The UK Hib vaccine experience

  2002cites this paper
• Immune Responses to Novel Pneumococcal Proteins Pneumolysin, PspA, PsaA, and CbpA in Adenoidal B Cells from Children

  2002cites this paper
• Evolution of conjugate vaccines

  2002cites this paper
• Mucosal immune responses to meningococcal conjugate polysaccharide vaccines in infants

  2002cites this paper
• Primary and Booster Mucosal Immune Responses to Meningococcal Group A and C Conjugate and Polysaccharide Vaccines Administered to University Students in the United Kingdom

  2001cites this paper
• Serum and salivary anti-capsular antibodies in infants and children vaccinated with octavalent pneumococcal conjugate vaccines, PncD and PncT.

  2001cites this paper
• Serum and salivary anti-capsular antibodies in infants and children immunized with the heptavalent pneumococcal conjugate vaccine

  2001cites this paper
• Pneumococcal carriage and otitis media induce salivary antibodies to pneumococcal surface adhesin a, pneumolysin, and pneumococcal surface protein a in children.

  2001cites this paper
• Efficacy of pneumococcal conjugate vaccines and their effect on carriage and antimicrobial resistance.

  2001cites this paper
• Development of a chemiluminescent optical fiber immunosensor to detect Streptococcus pneumoniae antipolysaccharide antibodies

  2000cites this paper
• Experience with the prevention of invasive Haemophilus influenzae type b disease by vaccination in Alaska: the impact of persistent oropharyngeal carriage.

  2000cites this paper
• Mucosal Immune Responses to Meningococcal Group C Conjugate and Group A and C Polysaccharide Vaccines in Adolescents

  2000cites this paper
• Primary and booster salivary antibody responses to a 7-valent pneumococcal conjugate vaccine in infants.

  2000cites this paper
• The potential for using protein vaccines to protect against otitis media caused by Streptococcus pneumoniae.

  2000cites this paper
• Salivary antibody response to vaccination with meningococcal A/C polysaccharide vaccine in previously vaccinated and unvaccinated Gambian children.

  2000cites this paper
• Dynamics of natural immunity caused by subclinical infections, case study on Haemophilus influenzae type b (Hib)

  2000cites this paper
• Salivary anti-capsular antibodies in infants and children immunised with Streptococcus pneumoniae capsular polysaccharides conjugated to diphtheria or tetanus toxoid.

  2000cites this paper
• Salivary antibodies following parenteral immunization of infants with a meningococcal serogroup A and C conjugated vaccine

  1999cites this paper
• Prophylaxis of bacterial meningitis.

  1999cites this paper
• Transcutaneous Immunization with Bacterial ADP-Ribosylating Exotoxins as Antigens and Adjuvants

  1999cites this paper
• ANTIBODIES INDUCED BY THE CAPSULAR POLYSACCHARIDE OF STREPTOCOCCUS PNEUMONIAE AFTER PARENTERAL IMMUNISATION AND IN ACUTE OTITIS MEDIA by Tea

  1999cites this paper
• Pneumococcal conjugate vaccination in toddlers: mucosal antibody response measured as circulating antibody-secreting cells and as salivary antibodies.

  1999cites this paper
• The Hib immunization programme in the Oxford region: an analysis of the impact of vaccine administration on the incidence of disease

  1999cites this paper
• Combined vaccination of Haemophilus influenzae type b conjugate and diphtheria-tetanus-pertussis containing acellular pertussis.

  1999cites this paper
• A Hierarchical Bayesian Model to Predict the Duration of Immunity to Haemophilus Influenzas Type B

  1999cites this paper
• Perspective: a five-country analysis of the impact of four different Haemophilus influenzae type b conjugates and vaccination strategies in Scandinavia.

  1999cites this paper
• [At which age does one acquire immunity against the main pathogenic agents in the first years of life? Is there an ideal age for entering into the community?].

  1999cites this paper
• Quel est l'âge d'acquisition de l'immunité contre les principaux agents pathogènes dans les premières années de vie ? Y a-t-il un âge idéal pour entrer en collectivité ?

  1999cites this paper
• Pneumococcal conjugate vaccination in adults: circulating antibody secreting cell response and humoral antibody responses in saliva and in serum.

  1998cites this paper
• Subclass distribution of IgA antibodies in saliva and serum after immunization with Haemophilus influenzae type b conjugate vaccines

  1998cites this paper
• Anticapsular polysaccharide antibodies and nasopharyngeal colonization with Streptococcus pneumoniae in infant rats.

  1998cites this paper
• Double-blind vaccine-controlled randomised efficacy trial of an investigational Shigella sonnei conjugate vaccine in young adults.

  1997cites this paper
• Immune responses of infants vaccinated with serotype 6B pneumococcal polysaccharide conjugated with tetanus toxoid.

  1997cites this paper
• Reduction of pneumococcal nasopharyngeal carriage in early infancy after immunization with tetravalent pneumococcal vaccines conjugated to either tetanus toxoid or diphtheria toxoid.

  1997cites this paper
• Detection of Antibodies toShigellaLipopolysaccharide in Urine after NaturalShigellaInfection or Vaccination

  1996cites this paper
• Conjugate vaccines and the carriage of Haemophilus influenzae type b.

  1996cites this paper
• Detection of antibodies to Shigella lipopolysaccharide in urine after natural Shigella infection or vaccination

  1996cites this paper
• Reduction of nasopharyngeal carriage of pneumococci during the second year of life by a heptavalent conjugate pneumococcal vaccine.

  1996cites this paper
• Mucosal antibodies to human cytomegalovirus glycoprotein B occur following both natural infection and immunization with human cytomegalovirus vaccines.

  1996cites this paper
• Mechanism of antibody-mediated reduction of nasopharyngeal colonization by Haemophilus influenzae type b studied in an infant rat model.

  1996cites this paper
• New vaccines for the prevention of pneumococcal infections.

  1996cites this paper